Giuseppe Grosso

Papers

1

Total Citations

47

H-Index

1

About

Giuseppe Grosso is a leading urological researcher whose work centers on improving the accuracy of prostate cancer (PCa) detection through advanced imaging and targeted biopsy techniques. His major contributions lie in evaluating the concordance between multiparametric magnetic resonance imaging (mpMRI) and definitive histopathology following radical prostatectomy. In his highly cited 2020 study (47 citations), Grosso demonstrated that MRI-targeted fusion biopsy significantly enhances the detection of clinically significant PCa while reducing the identification of indolent disease. By comparing side-of-lesion and Gleason Score agreement between targeted/systematic biopsies and final surgical specimens, he provided critical evidence supporting the integration of mpMRI into routine diagnostic pathways. This work has directly influenced clinical protocols, helping to minimize unnecessary biopsies and overtreatment. Grosso’s research bridges radiology and surgical pathology, offering a roadmap for more personalized, less invasive prostate cancer management. His findings continue to shape guidelines and inspire further investigation into precision diagnostics for urologic malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
The role of multiparametric resonance and biopsy in prostate cancer detection: comparison with definitive histological report after laparoscopic/robotic radical prostatectomy
47 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 7

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago